Pierre Gravier, CHIEF FINANCIAL OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 4,670 shares at $50.10 ($234K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Scheduled sale ($234k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.10 | 1,168 | $59K | 25.0% |
| 2 | $50.10 | 1,168 | $59K | 25.0% |
| 3 | $50.12 | 1,167 | $58K | 25.0% |
| 4 | $50.12 | 1,167 | $58K | 25.0% |
| Total | $50.11 avg | 4,670 | $234K | 100% |
| Filing → |
| PTCT | SELL | 2026-01-08 | $165K | — | Filing → |
| PTCT | SELL | 2025-07-17 | $249K | — | Filing → |
| PTCT | SELL | 2024-07-18 | $154K | — | Filing → |